TC BioPharm Holdings Plc (TCBP)

[resx18]

Great start @Mrogers23 welcome to $TCBP

[Mrogers23]

Nice to see 2x a G vol early

[resx18]

The FDA will review the application and determine the acceptability of the data before TC BioPharm begins its first clinical trial for TCB-008 It is possible that the FDA will require additional information.

[resx18]

Bryan Kobel (great CEO) of $TCBP said . "The IND application leverages supporting clinical study data from ongoing studies in patients with Acute Myeloid Leukemia and is also a reflection of substantial pre-clinical IND enabling work done over the course of the last 6 months by the TCB team. I would like to thank our entire team, who worked tirelessly to complete the Company's first ever US FDA trial filing. We look forward to working closely with the FDA to garner acceptance of our IND over the coming 30 days and advancing our lead candidate through clinical phases of development."

[resx18]

$TCBP loaded last week

[resx18]

Welcome onboard jedijazz! $TCBP

[resx18]

"Filing of the IND for TCB-008 is the next step in the clinical development of TCB-008 and aligns with our strategic refocus announced in Q2 of this year to target our clinical strategy to US trials in the future." said Bryan Kobel, Chief Executive Officer of TC BioPharm. "The IND application leverages supporting clinical study data from ongoing studies in patients with Acute Myeloid Leukemia and is also a reflection of substantial pre-clinical IND enabling work done over the course of the last 6 months by the TCB team. I would like to thank our entire team, who worked tirelessly to complete the Company's first ever US FDA trial filing. We look forward to working closely with the FDA to garner acceptance of our IND over the coming 30 days and advancing our lead candidate through clinical phases of development."

[jedijazz]

Great alert @Ryguy008

[resx18]

Reminds me of Dice .. $TCBP

[resx18]

Awesome 500k volume on news $TCBP

[resx18]

.45's up +20% $TCBP

[Ryguy008]

Big boys entered the building last night and today. Last week slow

$TCBP

[resx18]

$TCBP premarket news on a Monday got #shorts by the ballz .. #MOASS

[resx18]

https://stocktwits.com/resx18/message/548683881

[resx18]

EDINBURGH, Scotland , Oct. 23, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for the use of TCB-008 in the treatment of relapse/refractory Acute Myeloid Leukemia. TCB-008, an allogeneic unmodified gamma delta t-cell, is the Company's lead product and is currently in Phase 2b trials in the U.K. for the treatment of AML.).

TC BioPharm (PRNewsfoto/TC BioPharm)

The IND application leverages pioneering research on the use of Gamma Deltas in the treatment of relapse/refractory Acute Myeloid Leukemia. TCB-008 has been designated Orphan Drug Status in the treatment arena of AML previously.

"Filing of the IND for TCB-008 is the next step in the clinical development of TCB-008 and aligns with our strategic refocus announced in Q2 of this year to target our clinical strategy to US trials in the future." said Bryan Kobel, Chief Executive Officer of TC BioPharm. "The IND application leverages supporting clinical study data from ongoing studies in patients with Acute Myeloid Leukemia and is also a reflection of substantial pre-clinical IND enabling work done over the course of the last 6 months by the TCB team. I would like to thank our entire team, who worked tirelessly to complete the Company's first ever US FDA trial filing. We look forward to working closely with the FDA to garner acceptance of our IND over the coming 30 days and advancing our lead candidate through clinical phases of development."

The FDA will review the application and determine the acceptability of the data before TC BioPharm begins its first clinical trial for TCB-008 It is possible that the FDA will require additional information.

[resx18]

Did you see the update? $TCBP

[resx18]

$TCBP Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML https://t.co/JKClM0cJqR

— resx18 (@resx18) October 23, 2023

[resx18]

$TCBP Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML https://ir.tcbiopharm.com/news/press-releases/detail/64/tc-biopharm-announces-submission-of-investigational-new

[resx18]

$TCBP Chart

[resx18]

Good idea imo. $TCBP needs $1.00 to stay on #NASDAQ so this will be a fun ride up!

[Ryguy008]

Last week silent this week sparks ready to fly

$TCBP

[resx18]

$TCBP TC BioPharm Maintains #Nasdaq Listing
https://www.prnewswire.com/news-releases/tc-biopharm-maintains-nasdaq-listing-301889218.html

[resx18]

Welcome to the party! $TCBP

[resx18]

Good Morning $TCBP

[Ryguy008]

Bzzzzzzzz

$TCBP

[Ryguy008]

$TCBP

[whytestocks]

Clock struck two

[resx18]

tick .. tock..

[resx18]

Next week will be epic $TCBP

[resx18]

Nice start.. $TCBP

[resx18]

Good Morning $TCBP

[resx18]

Agreed $TCBP

[rbb]

been loading, need an update...

[resx18]

Loading Zone $TCBP

[resx18]

Good Morning $TCBP

[resx18]

.4236 ah $TCBP

[resx18]

On the bid .405 $TCBP

[resx18]

Same move coming as last year imo

[resx18]

We need $1

[resx18]

Things looking great here

[resx18]

Good Afternoon $TCBP

[stock1ace1]

Welp that pump didnt last long

[rbb]

added a few on this dip... $TCBP

[stock1ace1]

Frontloaders unloading laughable

[stock1ace1]

P&D

[Monksdream]

TCBP new 52 week low

[Monksdream]

TCBP new 52 week low

[glenn1919]

TCBP..................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783

[Junno1616]

~ $TCBP ~ setting up

[Junno1616]

~ $TCBP ~ Round 2, low float moves on light volume. Load n lock your shares GTC so they can't use them to short
#BeingFirstMcMatters